SIGA Technologies Inc Asset Resilience Ratio
SIGA Technologies Inc asset resilience ratio. SIGA Technologies Inc (SIGA) has an Asset Resilience Ratio of 2.85% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SIGA total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of SIGA Technologies Inc (2009–2017)
Asset resilience ratio of SIGA Technologies Inc from 2009 to 2017. This chart shows how SIGA Technologies Inc's Asset Resilience Ratio has changed over time. See SIGA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down SIGA Technologies Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SIGA Technologies Inc total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $4.09 Million | 2.85% |
| Total Liquid Assets | $4.09 Million | 2.85% |
Asset Resilience Insights
- Limited Liquidity: SIGA Technologies Inc maintains only 2.85% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SIGA Technologies Inc Industry Peers by Asset Resilience Ratio
Compare SIGA Technologies Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Curaleaf Holdings Inc.
TO:CURA |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL |
Drug Manufacturers - Specialty & Generic | 5.90% |
|
Zhejiang Medicine Co Ltd
SHG:600216 |
Drug Manufacturers - Specialty & Generic | 1.85% |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799 |
Drug Manufacturers - Specialty & Generic | 0.40% |
|
Dezhan HealthCare Co Ltd
SHE:000813 |
Drug Manufacturers - Specialty & Generic | 0.09% |
|
Chongqing Pharscin Pharmaceutical Co Ltd
SHE:002907 |
Drug Manufacturers - Specialty & Generic | 14.54% |
SIGA Technologies Inc Asset Resilience Ratio by Year (2009–2017)
SIGA Technologies Inc asset resilience ratio by year from 2009 to 2017. The table below shows the annual Asset Resilience Ratio data for SIGA Technologies Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 7.40% | $10.70 Million | $144.67 Million | +1.10pp |
| 2016-12-31 | 6.30% | $10.14 Million | $160.98 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $185.73 Million | -- |
| 2014-12-31 | 2.40% | $4.00 Million | $166.39 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $193.82 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $105.84 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $90.38 Million | -- |
| 2010-12-31 | 55.49% | $15.00 Million | $27.03 Million | +36.20pp |
| 2009-12-31 | 19.29% | $5.00 Million | $25.92 Million | -- |
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.